EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma.
- Resource Type
- Article
- Source
- Cell Discovery; 8/23/2022, Vol. 8 Issue 1, p1-4, 4p
- Subject
EPIDERMAL growth factor receptors HEPATOCELLULAR carcinoma ERLOTINIB DASATINIB CLINICAL trials - Language
- ISSN
- 20565968